Claudin 18.2 Targeted Therapy Market Forecast & Clinical Trials Insights Report 2024-2029: Innovent, MabWorks, and Biotheus are Making Substantial Progress
22 nov. 2024 04h49 HE
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Claudin 18.2 Targeted Therapy Market Forecast & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. ...
Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
21 nov. 2024 08h00 HE
|
Science 37, Inc.
Science 37 contributes almost half (47%) of the U.S. enrollment for GSK Phase 3 rare disease study while bolstering participant retention figures.
Agenda Announced for 2025 MDA Clinical & Scientific Conference Featuring Leading Speakers Dedicated to Groundbreaking Research and Clinical Achievements in Neuromuscular Disease
14 nov. 2024 09h00 HE
|
Muscular Dystrophy Association
New York, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association today announced the agenda including tracks and Chairs for the 2025 MDA Clinical & Scientific Conference being held...
Medeloop Secures $15.5 Million in Series A Funding to Accelerate Medical Research
13 nov. 2024 08h00 HE
|
Medeloop
MENLO PARK, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Medeloop, the pioneering medical research platform announces the close of its $15.5 million Series A funding round. Led by global venture...
Next Generation Sequencers (NGS) Market Set to Surge at 8.3% CAGR, to Reach USD 2.4 billion by 2031 | Transparency Market Research, Inc.
08 nov. 2024 07h32 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The next generation sequencers (NGS) industry (차세대 시퀀서(NGS) 산업) was valued at US$ 1.2...
Collaborative effort to conduct a study aimed at improving the diagnosis of Alzheimer’s and related dementias for everyone
28 oct. 2024 10h00 HE
|
Global Alzheimer’s Platform Foundation®
Washington D.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome the initial strategic partners in the Bio-Hermes-002 study. These...
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024
28 oct. 2024 09h00 HE
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving...
Phase III trial results of novel triple combination pill for hypertension published in The Lancet
18 oct. 2024 07h00 HE
|
George Medicines
Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill significantly reduced blood pressure and improved control rates vs dual...
Ivy Brain Tumor Center to Present Multiple Abstracts and a Special Session on Innovative Clinical Trial Design at the 2024 European Association of Neuro-Oncology Annual Meeting
17 oct. 2024 06h00 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute will present updated study results and a special session on clinical trial design at the...
Clinical Trials Market Size to Worth USD 85.37 Billion by 2033 | Straits Research
15 oct. 2024 10h55 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Clinical trials are critical in proceeding with medical knowledge and improving patient care. They involve a rigorous process of recruiting...